GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Neuca SA (WAR:NEU) » Definitions » Net Income Including Noncontrolling Interests

Neuca (WAR:NEU) Net Income Including Noncontrolling Interests : zł167 Mil (TTM As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Neuca Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Neuca's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2024 was zł60 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 was zł167 Mil.

Neuca Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Neuca's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuca Net Income Including Noncontrolling Interests Chart

Neuca Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only 117.45 143.26 152.55 149.35 159.46

Neuca Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.05 23.93 50.63 32.84 59.58

Neuca Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł167 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuca Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Neuca's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuca (WAR:NEU) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Neuca SA (WAR:NEU) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
IST:BRISA IST:FROTO IST:SAFKR IST:JANTS IST:DOAS IST:ASUZU IST:GOODY IST:KARSN IST:OTKAR IST:FMIZP WBA BSP:RADL3 HKSE:00241 TSE:3088 SAU:4164 SHSE:603939 TSE:3349 SHSE:600998 HKSE:09885 TSE:3391
Traded in Other Exchanges
7HD:Germany
Address
ul. Forteczna 35?37, Torun, POL, 87-100
Website
https://www.neuca.pl
Neuca SA is a wholesale distributor of pharmaceuticals in Poland. The company's segment includes Pharmacy wholesale; Manufacture of pharmaceuticals; Outpatient medical care clinics; Clinical trials and Insurance activities. It generates maximum revenue from the Pharmacy wholesale segment.